Treatment of Lp(a): Is It the Future or Are We Ready Today?

Abstract excerpt

PURPOSE OF REVIEW: The goal of this review is to present the pharmacodynamic effectiveness as well as the clinical efficacy and safety of investigational antisense oligonucleotides (ASOs) and small interference RNAs (siRNAs) drugs that specifically target lipoprotein(a) (Lp(a)). The review will discuss whether the existing lipid-lowering therapies are adequate to treat high Lp(a) levels or whether it is necessary...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Atherosclerosis and Cardiovascular Diseases
• Share to Lipoproteins and Cardiovascular Health
• Share to Viral Infections and Immunology Research